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Netherlands.Introduction
Implantable cardioverter-deﬁbrillator (ICD) implantation
may be challenging in patients with lack of venous access
and who are not suitable for a standard subcutaneous ICD (S-
ICD).Case report
A 51-year-old man with a dilated cardiomyopathy with a left
ventricular ejection fraction of 10% was transferred to our
hospital. The patient was known to have superior vena cava
(SVC) syndrome related to a JAK2 mutation. He had several
hospital admissions in the past with heart failure. His current
NYHA class is II–III on optimal heart failure medication.
During his hospital stay he experienced several episodes of
nonsustained ventricular tachycardia. The patient had,
according to current guidelines, a class I indication for an
ICD.1 The patient was recompensated and he was discharged
from the hospital with a wearable deﬁbrillator (LifeVest,
Cardio Solutions B.V., Landsmeer, The Netherlands) until
placement of a deﬁnitive ICD.
SVC occlusion precluded implantation of endovascular
ICD by a superior approach (Figure 1). Furthermore,
implantation of an endovascular ICD by a femoral approach
was deemed not appropriate considering his high risk of
venous thrombosis secondary to his JAK2 mutation and we
chose not to use epicardial patches to prevent the risk of
restrictive pericarditis. He was also not a suitable candidate
for an S-ICD because he had an unfavorable R/T-wave ratioKEYWORDS Substernal shock lead; Epicardial pace/sense electrode; Implan-
table cardioverter-deﬁbrillator; Superior vena cava syndrome
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ventricular tachycardia, and conduction abnormalities.2
We implanted a conventional ICD (Evera MRI XT
Surescan DVMB2D4, Medtronic, Minneapolis, MN) in the
left mid-axillary line at the 5th–6th intercostal space,
combined with a standard epicardial pace/sense electrode
(Myodex 1084T, St Jude Medical, St Paul, MN) via a left-
sided mini-thoracotomy, and a substernal SVC coil (Trans-
vene-SVC, Medtronic) with the standard tunneling tool from
the S-ICD with an 11 F peel-away sheath. The substernal
tunneling was performed under thoracoscopy guidance (see
online movie). Both the epicardial pace/sense electrode and
the substernal shock electrode were then tunneled to the left
lateral pocket.
Conventional ICDs have a maximal energy delivery of 40
J. In S-ICDs the deﬁbrillation safety margin test is performed
at 65 J and the ICD shock therapy is set at 80 J. We
hypothesize that if we place the shock lead in a parasternal
subcutaneous position the patient would probably need more
than 40 J to successful deﬁbrillate ventricular ﬁbrillation.
That is why we decided to implant the SVC coil lead in a
substernal position. The patient underwent a successfulFigure 1 Left- and right-sided venograms showing bilateral occlusion of
the subclavian veins.
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KEY TEACHING POINTS
 Endovascular implantable cardioverter-deﬁbrillator
(ICD) placement may be hampered by venous
access issues.
 Placement of substernal ICD lead by using a
tunneling tool is feasible and the lead remains
stable over time.
 A substernal ICD may be a useful alternative in
selected patients with superior vena cava
syndrome, especially those deemed not suitable for
a subcutaneous ICD and those who may beneﬁt
from antitachycardia pacing.
Heart Rhythm Case Reports, Vol 0, No 0, Month 20162deﬁbrillation test at 40 J and had an uneventful recovery. The
chest radiograph in the anteroposterior and left lateralFigure 2 Electroprojection shows the ﬁnal position of the ICD and leads 3
months after implantation demonstrating the stable lead
position (Figure 3).
This is, as far as we know, the second description of an
ICD implantation using a substernal ICD lead.3 However, it
is the ﬁrst with a conventional ICD combined with an
epicardial pace/sense electrode. It presents a good alternative
for patients who are not candidates for a transvenous or a
subcutaneous ICD. An additional beneﬁt of this system is
that the patient also has a possibility for pacing in case of
bradycardia, and also antitachycardia pacing in case of
sustained ventricular tachycardia s.cardiogram.
Figure 3 Chest radiograph 3 months after implantation in anteroposterior and left lateral projection.A: Substernal implantable cardioverter-deﬁbrillator (ICD)
lead. B: Epicardial pace/sense electrode. C: Left lateral midaxillary-placed conventional ICD can.
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Supplementary data associated with this article can be found
in the online version at http://dx.doi.org/10.1016/j.hrcr.2016.
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